All Stories

  1. Runx1 Orchestrates Sphingolipid Metabolism and Glucocorticoid Resistance in Lymphomagenesis

    Article • Journal of Cellular Biochemistry, January 2017, Wiley

    Prof James C Neil

  2. Feline leukemia virus : assessing risk of zoonosis

    Article • Journal of Virology, December 2016, ASM Journals

    Prof James C Neil

  3. Addiction to RUNX in lymphoma

    Article • Aging, September 2016, Impact Journals, LLC

    Prof James C Neil

  4. Addiction to Runx1 is partially attenuated by loss of p53 in the Eµ-Myc lymphoma model

    Article • Oncotarget, April 2016, Impact Journals, LLC

    Prof James C Neil

  5. Gamma retroviruses preferentially integrate near cancer genes

    Article • PLoS ONE, April 2016, PLOS

    Prof James C Neil

  6. Runx2 contributes to the regenerative potential of the mammary epithelium

    Article • Scientific Reports, October 2015, Nature

    Prof James C Neil

  7. Frequent Infection of Human Cancer Xenografts with Murine Endogenous Retroviruses in Vivo

    Article • Viruses, April 2015, MDPI AG

    Prof James C Neil

  8. How does koala retrovirus (KoRV) induce disease at the genomic level?

    Article • Technical Reports of the Australian Museum online, May 2014, Australian Museum

    Prof James C Neil

  9. RUNX2 correlates with subtype-specific breast cancer in a human tissue microarray, and ectopic expression of Runx2 perturbs differentiation in the mouse mammary gland

    Article • Disease Models & Mechanisms, March 2014, The Company of Biologists

    Prof James C Neil

  10. Insertional Mutagenesis and Deep Profiling Reveals Gene Hierarchies and a Myc/p53-Dependent Bottleneck in Lymphomagenesis

    Article • PLoS Genetics, February 2014, PLOS

    Prof James C Neil

  11. Feline Leukaemia Virus

    Article • April 2012, Wiley

    Prof James C Neil

  12. Genome-wide screening in human growth plates during puberty in one patient suggests a role for RUNX2 in epiphyseal maturation

    Article • Journal of Endocrinology, February 2011, Bioscientifica

    Prof. Dr. Bas E. Dutilh, Prof James C Neil

  13. Runx2 in normal tissues and cancer cells: A developing story

    Article • Blood Cells Molecules and Diseases, August 2010, Elsevier

    Prof James C Neil

  14. Runx Regulation of Sphingolipid Metabolism and Survival Signaling

    Article • Cancer Research, June 2010, American Association for Cancer Research (AACR)

    Prof James C Neil

  15. Viral Oncogenicity

    Article • March 2010, Wiley

    Prof James C Neil

  16. ETV6/RUNX1 abrogates mitotic checkpoint function and targets its key player MAD2L1

    Article • Oncogene, March 2010, Nature

    Prof James C Neil

  17. Runx1 promotes B-cell survival and lymphoma development

    Article • Blood Cells Molecules and Diseases, July 2009, Elsevier

    Prof James C Neil

  18. A Novel Model of SCID-X1 Reconstitution Reveals Predisposition to Retrovirus-induced Lymphoma but No Evidence of γC Gene Oncogenicity

    Article • Molecular Therapy, June 2009, Elsevier

    Prof James C Neil

  19. RUNX1 and its fusion oncoprotein derivative, RUNX1-ETO, induce senescence-like growth arrest independently of replicative stress

    Article • Oncogene, May 2009, Nature

    Prof James C Neil

  20. Oncogene-induced senescence: An essential role for Runx

    Article • Cell Cycle, August 2008, Taylor & Francis

    Prof James C Neil

  21. Gene array analysis reveals a common Runx transcriptional programme controlling cell adhesion and survival

    Article • Oncogene, June 2008, Nature

    Prof James C Neil

  22. Feline Leukemia and Sarcoma Viruses

    Article • January 2008, Elsevier

    Prof James C Neil

  23. Runx2 Disruption Promotes Immortalization and Confers Resistance to Oncogene-Induced Senescence in Primary Murine Fibroblasts

    Article • Cancer Research, December 2007, American Association for Cancer Research (AACR)

    Prof James C Neil

  24. Insertional Mutagenesis Reveals Progression Genes and Checkpoints in MYC/Runx2 Lymphomas

    Article • Cancer Research, June 2007, American Association for Cancer Research (AACR)

    Prof James C Neil

  25. Prime-boost vaccination using DNA and whole inactivated virus vaccines provides limited protection against virulent feline immunodeficiency virus

    Article • Vaccine, November 2006, Elsevier

    Prof James C Neil

  26. Gene therapy: X-SCID transgene leukaemogenicity

    Article • Nature, September 2006, Nature

    Prof James C Neil

  27. Limited efficacy of an inactivated feline immunodeficiency virus vaccine

    Article • Veterinary Record, April 2006, BMJ

    Prof James C Neil

  28. Runx2 and MYC Collaborate in Lymphoma Development by Suppressing Apoptotic and Growth Arrest Pathways In vivo

    Article • Cancer Research, February 2006, American Association for Cancer Research (AACR)

    Prof James C Neil

  29. The runx genes: gain or loss of function in cancer

    Article • Nature Reviews Drug Discovery, April 2005, Nature

    Prof James C Neil

  30. Vaccination with an Inactivated Virulent Feline Immunodeficiency Virus Engineered To Express High Levels of Env

    Article • Journal of Virology, February 2005, ASM Journals

    Prof James C Neil

  31. Conservation and expression of an alternative 3′ exon of Runx2 encoding a novel proline-rich C-terminal domain

    Article • Gene, July 2004, Elsevier

    Prof James C Neil

  32. The Runx genes: lineage-specific oncogenes and tumor suppressors

    Article • Oncogene, May 2004, Nature

    Prof James C Neil

  33. Nomenclature for Runt-related (RUNX) proteins

    Article • Oncogene, May 2004, Nature

    Prof James C Neil

  34. RUNX1 transformation of primary embryonic fibroblasts is revealed in the absence of p53

    Article • Oncogene, May 2004, Nature

    Prof James C Neil

  35. Mutations in the candidate tumour suppressor gene FLJ12973 on chromosome 15q15 are rare in colorectal cancer

    Article • Cancer Letters, June 2003, Elsevier

    Prof James C Neil

  36. The Runx genes as dominant oncogenes

    Article • Blood Cells Molecules and Diseases, March 2003, Elsevier

    Prof James C Neil

  37. Long-Range Effects of Retroviral Insertion on c-myb: Overexpression May Be Obscured by Silencing during Tumor Growth In Vitro

    Article • Journal of Virology, January 2003, ASM Journals

    Prof James C Neil

  38. Retroviral insertion sites and cancer: Fountain of all knowledge?

    Article • Cancer Cell, October 2002, Elsevier

    Prof James C Neil

  39. Enforced Expression of Runx2 Perturbs T Cell Development at a Stage Coincident with  -Selection

    Article • The Journal of Immunology, September 2002, The American Association of Immunologists

    Prof James C Neil

  40. Evolution of Replication Efficiency following Infection with a Molecularly Cloned Feline Immunodeficiency Virus of Low Virulence

    Article • Journal of Virology, June 2002, ASM Journals

    Prof James C Neil

  41. The Common Retroviral Insertion Locus Dsi1 Maps 30 Kilobases Upstream of the P1 Promoter of the Murine Runx3/Cbfa3/Aml2 Gene

    Article • Journal of Virology, May 2002, ASM Journals

    Prof James C Neil

  42. Linkage on chromosome 10 of several murine retroviral integration loci associated with leukaemia

    Article • Journal of General Virology, April 2002, Society for General Microbiology

    Prof James C Neil

  43. Protection against feline immunodeficiency virus using replication defective proviral DNA vaccines with feline interleukin-12 and -18

    Article • Vaccine, February 2002, Elsevier

    Prof James C Neil

  44. Feline Leukemia Virus DNA Vaccine Efficacy Is Enhanced by Coadministration with Interleukin-12 (IL-12) and IL-18 Expression Vectors

    Article • Journal of Virology, September 2001, ASM Journals

    Prof James C Neil

  45. Runx2: A novel oncogenic effector revealed by in vivo complementation and retroviral tagging

    Article • Oncogene, January 2001, Nature

    Prof James C Neil

  46. Sensitivity to myc-induced apoptosis is retained in spontaneous and transplanted lymphomas of CD2-mycERTM mice

    Article • Oncogene, March 2000, Nature

    Prof James C Neil

  47. A full-length Cbfa1 gene product perturbs T-cell development and promotes lymphomagenesis in synergy with MYC

    Article • Oncogene, November 1999, Nature

    Prof James C Neil

  48. FELINE LEUKEMIA AND SARCOMA VIRUSES (RETROVIRIDAE)

    Article • January 1999, Elsevier

    Prof James C Neil

  49. Feline immunodeficiency virus (FIV)-associated lymphoma: a potential role for immune dysfunction in tumourigenesis

    Article • Veterinary Immunology and Immunopathology, October 1998, Elsevier

    Prof James C Neil

  50. p53 and tumour viruses: Catching the guardian off-guard

    Article • Trends in Microbiology, March 1997, Elsevier

    Prof James C Neil

  51. Common mechanism of infection by lentiviruses

    Article • Nature, February 1997, Nature

    Prof James C Neil

  52. A Common Proviral Integration Region, fit-1, in T-Cell Tumors Induced by Myc-Containing Feline Leukemia Viruses

    Article • Virology, October 1993, Elsevier

    Prof James C Neil

  53. Enhancement after feline immunodeficiency virus vaccination

    Article • Veterinary Immunology and Immunopathology, December 1992, Elsevier

    Prof James C Neil

  54. Productive infection of T-helper lymphocytes with feline immunodeficiency virus is accompanied by reduced expression of CD4

    Article • AIDS, December 1991, Wolters Kluwer Health

    Prof James C Neil

  55. Immunodiagnosis of feline immunodeficiency virus infection using recombinant viral p17 and p24

    Article • AIDS, December 1991, Wolters Kluwer Health

    Prof James C Neil

  56. Feline immunodeficiency virus as a model for AIDS vaccination

    Article • AIDS, January 1990, Wolters Kluwer Health

    Prof James C Neil

  57. Viral transduction of cellular genes in naturally-occurring feline leukaemias

    Article • European Journal of Cancer and Clinical Oncology, November 1987, Elsevier

    Prof James C Neil

  58. Recombinant feline viruses containing themyc gene rapidly produce clonal tumours expressing T-cell antigen receptor gene transcripts

    Article • International Journal of Cancer, July 1987, Wiley

    Prof James C Neil

  59. Altered structure and expression of c-myc in Feline T-cell tumours

    Article • Virology, May 1987, Elsevier

    Prof James C Neil

  60. Retroviral transduction of T-cell antigen receptor β-chain and myc genes

    Article • Nature, March 1987, Nature

    Prof James C Neil

  61. Conservation of the c-myc coding sequence in transduced feline v-myc genes

    Article • Virology, October 1986, Elsevier

    Prof James C Neil

  62. Transduction and rearrangement of the myc gene by feline leukaemia virus in naturally occurring T-cell leukaemias

    Article • Nature, April 1984, Nature

    Prof James C Neil

  63. ts transformation mutants of avian sarcoma virus PRCII: Lack of strict correlation between transforming ability and properties of the P105-associated kinase

    Article • Virology, February 1983, Elsevier

    Prof James C Neil

  64. Defective Avian Sarcoma Viruses

    Article • January 1983, Springer Science + Business Media

    Prof James C Neil

  65. Structural similarities of proteins encoded by three classes of avian sarcoma viruses

    Article • Virology, September 1982, Elsevier

    Prof James C Neil

  66. Cleavage of four avian sarcoma virus polyproteins with virion protease p15 removes gag sequences and yields large fragments that function as tyrosine phosphoacceptors in vitro.

    Article • Proceedings of the National Academy of Sciences, September 1981, Proceedings of the National Academy of Sciences

    Prof James C Neil

  67. The 28 S genomic RNA of avian sarcoma virus PRCII codes for the transformation-specific polyprotein P105

    Article • Virology, July 1981, Elsevier

    Prof James C Neil

  68. Homologous tyrosine phosphorylation sites in transformation-specific gene products of distinct avian sarcoma viruses

    Article • Nature, June 1981, Nature

    Prof James C Neil

  69. Esh avian sarcoma virus codes for a gag-linked transformation-specific protein with an associated protein kinase activity

    Article • Virology, June 1981, Elsevier

    Prof James C Neil

  70. A third class of avian sarcoma viruses, defined by related transformation-specific proteins of Yamaguchi 73 and Esh sarcoma viruses.

    Article • Proceedings of the National Academy of Sciences, April 1981, Proceedings of the National Academy of Sciences

    Prof James C Neil

  71. Tyrosine-specific protein kinase activity associated with p105 of avian sarcoma virus PRCII

    Article • Virology, February 1981, Elsevier

    Prof James C Neil

  72. The pathogenicity and defectiveness of PRCII: A new type of avian sarcoma virus

    Article • Virology, January 1981, Elsevier

    Prof James C Neil

  73. Characterization of a 105,000 molecular weightgag-related phosphoprotein from cells transformed by the defective avian sarcoma virus PRCII

    Article • Virology, January 1981, Elsevier

    Prof James C Neil

  74. PRCII, a Representative of a New Class of Avian Sarcoma Viruses

    Article • January 1981, Springer Science + Business Media

    Prof James C Neil

  75. GENETIC VARIATION AND HOST MARKERS IN THE src GENE OF RECOVERED AVIAN SARCOMA VIRUSES

    Article • Annals of the New York Academy of Sciences, November 1980, Wiley

    Prof James C Neil

  76. Polypeptides of Feline Leukaemia Virus: Identification of p15(E) and p12(E)

    Article • Journal of General Virology, October 1980, Society for General Microbiology

    Prof James C Neil

  77. Polypeptides of feline leukemia virus: A glycosylated gag-related protein is released into culture fluids

    Article • Virology, August 1980, Elsevier

    Prof James C Neil

  78. Recovered src genes are polymorphic and contain host markers

    Article • Virology, August 1980, Elsevier

    Prof James C Neil

  79. Cell-free translation of avian erythroblastosis virus RNA yields two specific and distinct proteins with molecular weights of 75,000 and 40,000

    Article • Virology, January 1980, Elsevier

    Prof James C Neil

  80. PRCII, A NEW TYPE OF AVIAN SARCOMA VIRUS

    Article • January 1980, Elsevier

    Prof James C Neil